Physician profile
Michael T Diment
NPI 1932168291
$1,023.52
in general payments reported to CMS, 2019-2025
17 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $164 · 2021: $64.92 · 2022: $66.25 · 2023: $32.64 · 2024: $231 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $229.51 | 2019-2025 | Tymlos |
| Amgen INC. | $114.09 | 2019-2025 | Evenity, Prolia |
| Smith+Nephew, INC. | $113.21 | 2020 | |
| Heron Therapeutics, INC. | $104.63 | 2024-2025 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $97.77 | 2019-2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Sanofi-Aventis U.S. LLC | $58.14 | 2019 | |
| Boston Scientific Corporation | $53.60 | 2022 | |
| Bioventus LLC | $45.99 | 2024-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Pacira Pharmaceuticals Incorporated | $31.63 | 2021-2023 | Exparel, Zilretta, Iovera |
| Pacira Therapeutics, INC. | $29.92 | 2019-2020 | |
| Pinnacle, INC | $28.13 | 2025 | |
| Stryker Corporation | $27.40 | 2024 | T2 Alpha |
| Sanara Medtech INC. | $23.96 | 2025 | Celleraterx |
| Ferring Pharmaceuticals INC. | $19.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.96 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $14.73 | 2019 | |
| Depuy Synthes Sales INC. | $13.11 | 2024 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Diment listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.